Categories: News

The Assistance Fund Opens New Program for Atopic Dermatitis

Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Atopic Dermatitis

ORLANDO, FL / ACCESSWIRE / April 1, 2024 / The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new copay assistance program for people living with atopic dermatitis. The program is designed to help eligible individuals pay for their out-of-pocket medical costs for treatment, such as copayments, coinsurance, and deductibles.

Atopic dermatitis, commonly known as eczema, is a skin condition leading to inflamed, itchy skin for children and adults.[1] Most people living with eczema experience dry skin or a rash that requires moisturizers and other treatment. The condition is not contagious and is often diagnosed in early childhood; however, adult-onset disease can occur as well.

“Atopic dermatitis is an incredibly burdensome condition that negatively impacts the health and quality of life of those affected by it,” said Julie Block, President and CEO of the National Eczema Association. “I’m grateful for The Assistance Fund’s new Atopic Dermatitis Financial Assistance Program, which will help people living with this chronic condition manage it with less worry about the cost of care and treatment.”

“People living with atopic dermatitis often face both physical discomfort and emotional distress,” said Danielle Vizcaino, President and CEO of The Assistance Fund. “Thanks to our donors, The Assistance Fund’s new Atopic Dermatitis Copay Assistance Program will provide children and adults living with eczema much-needed relief without the hurdle of cost.”

To learn more or determine eligibility for financial support, visit tafcares.org or call (833) 603-5297 to speak with a Patient Advocate.

A list of all the disease programs available from The Assistance Fund can be found on the website tafcares.org.

About The Assistance Fund

The Assistance Fund (TAF) is an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses. The Assistance Fund currently manages more than 90 disease programs, each of which covers all the FDA-approved medications that treat a specific disease named in the disease program. Since its founding in 2009, TAF has helped more than 190,000 children and adults access the treatment they need to stay healthy or manage a life-threatening, chronic, or rare disease. To learn more about The Assistance Fund, or for information on how to donate, please visit tafcares.org.

Media Contact

Margaret Figley
Senior Director of Communications
margaret.figley@tafcares.org

[1]What is Eczema?, National Eczema Association, https://nationaleczema.org/eczema, accessed February 2024.

Contact Information

Margaret Figley
Senior Director of Communications
margaret.figley@tafcares.org

SOURCE: The Assistance Fund

View the original press release on newswire.com.

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

15 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

15 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

15 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

15 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

15 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

15 hours ago